相关实验视频

Updated: May 6, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

循环氧化酶2在乳腺癌诊断中是否有效?

Nariman Kadhum Abdulrazza¹, Mazin Hawaz Al-Hawaz², Hussein G Abdul-Sada³

¹Board Candidate in Microbiology, General Directorate of Health, Basrah Iraq.

Asian Pacific journal of cancer prevention : APJCP

|December 29, 2025

概括

循环氧化酶-2 (COX2) 突变和表达水平显示了恶性和良性乳腺组织之间的显著差异. 这表明COX2可以作为一种有价值的生物标志物,用于在疑似患者中早期检测乳腺癌.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物标志物发现发现

背景情况:

乳腺癌是全球女性死亡的主要原因之一.
早期检测显著提高了生存率.
像COX2这样的分子标记物对于诊断和治疗至关重要.

研究的目的:

为了验证COX2基因突变与乳腺癌表达之间的相关性.
评估COX2作为诊断生物标记物的潜力.

主要方法:

在57名乳腺癌患者 (42名恶性,15名良性) 中,使用常规PCR将COX2基因分离出来.
进行了DNA测序,以确定COX2外基因中的突变.
在瘤组织,周围组织和血液样本中使用RT-PCR分析了COX2表达水平.

主要成果:

在30.3%的测序样本 (删除和替换) 中观察到COX2异构2的突变.
与良性组织相比,恶性组织和血液中检测到显著更高的COX2表达.
在恶性病例中,高COX2表达与年龄 (57-66岁) 相关.

结论:

在恶性和良性乳腺组织之间,COX2突变和表达模式显著不同.
COX2证明了其作为可靠的生物标志物在怀疑的个体中识别乳腺癌的潜力.
这项研究支持使用COX2作为伊拉克乳腺癌患者的诊断工具.

关键词:

COX2二氧化碳的使用.诊断诊断诊断诊断诊断乳腺癌乳腺癌乳腺癌

更多相关视频

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...